Myocarditis cardiac transplantation: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Myocarditis}} | {{Myocarditis}} | ||
{{CMG}} | {{CMG}} | ||
| Line 9: | Line 9: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
Revision as of 22:46, 22 August 2012
|
Myocarditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myocarditis cardiac transplantation On the Web |
|
American Roentgen Ray Society Images of Myocarditis cardiac transplantation |
|
Risk calculators and risk factors for Myocarditis cardiac transplantation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cardiac transplantation is sometimes required to treat refractory giant cell myocarditis. However, the condition can recur in post-transplant patients. Recurrence of biopsy proven giant cell myocarditis between 3 weeks to 9 years was observed in 9 of 34 cardiac transplant patients [1].
References
- ↑ Cooper LT, Berry GJ, Shabetai R (1997). "Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators". N Engl J Med. 336 (26): 1860–6. doi:10.1056/NEJM199706263362603. PMID 9197214.